Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Yaseen M. Arabi(World Health Organization), Fahad Al-Hameed, Yusri Taha, Ali H. Hajeer(King Saud bin Abdulaziz University for Health Sciences), Awad Al‐Omari(University of Central Florida), Kanakatte Raviprakash, Gail Carson, Hanan H. Balkhy(World Health Organization Regional Office for the Eastern Mediterranean), Abderrezak Bouchama(King Saud bin Abdulaziz University for Health Sciences), Khalid S. Al-Khairy, Musharaf Sadat, Saad Al-Qahtani, Sameera Al Johani, Robert Fowler(Sunnybrook Health Science Centre), Nahoko Shindo(World Health Organization), Frederick G. Hayden(Centers for Disease Control and Prevention), Thomas Luke(King Saud bin Abdulaziz University for Health Sciences), Abdulaziz Al‐Dawood
Cited by 259
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
COVID-19: what is next for public health?
|The Lancet|2020|1.2k